Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,576
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
for
Cushing Syndrome
Location: Cape Coral FL, Chicago IL, Weslaco TX, San Francisco CA
Sponsor: RECORDATI GROUP
Sex: All
Age: 2 - 17
Code: NCT03708900
Phase2, Recruiting
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Self Reported Level of Agitation of Patients Presenting to an Emergency Department
for
Psychiatric Issue
Location: Chicago IL
Sponsor: Leslie Zun, MD
Sex: All
Age: 18+
Code: NCT02713100
Recruiting
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
for
Cystic Fibrosis
Location: Boston MA, Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center
Sex: All
Age: 3 - 18
Code: NCT06654752
Recruiting
Effect of a Nutritional Supplement on H&N Cancer Patients
for
Head and Neck Cancer
Location: Hines IL
Sponsor: Edward Hines Jr. VA Hospital
Sex: All
Age: 30 - 70+
Code: NCT00296452
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Cabaletta Bio
Sex: All
Age: 6 - 70+
Code: NCT06154252
Phase2, Phase3, Recruiting
Study of Gastric Motility in Eosinophilic Gastritis
for
Eosinophilic Gastritis, Gastroparesis,
Location: Bethesda MD, Chicago IL, Salt Lake City UT
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18 - 59
Code: NCT05229432
Recruiting
Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID
for
Disabilities Multiple
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT05792852
Recruiting
Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
for
Prosthetic-joint Infection, Knee Infection,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06293352
Recruiting
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
for
Benign Prostatic Hyperplasia
Location: Glenview IL
Sponsor: Northwestern University
Sex: Male
Age: 50+
Code: NCT05898932
Recruiting
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
for
Recurrent Pericarditis
Location: Boston MA, New York NY, Burlington VT, Ottawa,
Sponsor: Zomagen Biosciences Ltd.
Sex: All
Age: 18 - 70+
Code: NCT06836232
Phase2, Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for
Functional Mitral Regurgitation, Heart Failure,
Location: Boston MA, New York NY, Edison NJ, Poughkeepsie NY,
Sponsor: Cardiac Dimensions, Inc.
Sex: All
Age: 18+
Code: NCT03142152
Recruiting
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
for
Dysphagia, Achalasia, Esophageal,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT06883175
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Boston MA, New Haven CT, New Brunswick NJ, Montreal,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)